Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Widera

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cell|April 8, 1988
Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cellsD Lo, L C Burkly, G Widera, et al.
The EMBO Journal|September 1, 1985
Tissue-specific, inducible and functional expression of the E alpha d MHC class II gene in transgenic miceC A Pinkert, G Widera, C Cowing, et al.
Biology of Reproduction|October 1, 1990
Infertility in male transgenic mice: disruption of sperm development by HSV-tk expression in postmeiotic germ cellsR E Braun, D Lo, C A Pinkert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1992
Expression of a functional chimeric Ig-MHC class II proteinJ Zwirner, W Weissenhorn, L Karlsson, et al.
Cell|October 23, 1987
Transgenic mice selectively lacking MHC class II (I-E) antigen expression on B cells: an in vivo approach to investigate Ia gene functionG Widera, L C Burkly, C A Pinkert, et al.
Journal of Virology|May 30, 1998
DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitinationF Rodriguez, L L An, S Harkins, et al.
Behring Institute Mitteilungen|February 1, 1997
Manipulation of immune responses via particle-mediated polynucleotide vaccinesW F Swain, M D Macklin, G Neumann, et al.
Gene Therapy|January 1, 1996
Selected strategies to augment polynucleotide immunizationR M Conry, G Widera, A F LoBuglio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
Increased DNA vaccine delivery and immunogenicity by electroporation in vivoG Widera, M Austin, D Rabussay, et al.
Annals of Surgery|September 1, 1995
Gene transfer to the thymus. A means of abrogating the immune response to recombinant adenovirusR P DeMatteo, S E Raper, M Ahn, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cell|April 8, 1988
Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cellsD Lo, L C Burkly, G Widera, et al.
The EMBO Journal|September 1, 1985
Tissue-specific, inducible and functional expression of the E alpha d MHC class II gene in transgenic miceC A Pinkert, G Widera, C Cowing, et al.
Biology of Reproduction|October 1, 1990
Infertility in male transgenic mice: disruption of sperm development by HSV-tk expression in postmeiotic germ cellsR E Braun, D Lo, C A Pinkert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1992
Expression of a functional chimeric Ig-MHC class II proteinJ Zwirner, W Weissenhorn, L Karlsson, et al.
Cell|October 23, 1987
Transgenic mice selectively lacking MHC class II (I-E) antigen expression on B cells: an in vivo approach to investigate Ia gene functionG Widera, L C Burkly, C A Pinkert, et al.
Journal of Virology|May 30, 1998
DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitinationF Rodriguez, L L An, S Harkins, et al.
Behring Institute Mitteilungen|February 1, 1997
Manipulation of immune responses via particle-mediated polynucleotide vaccinesW F Swain, M D Macklin, G Neumann, et al.
Gene Therapy|January 1, 1996
Selected strategies to augment polynucleotide immunizationR M Conry, G Widera, A F LoBuglio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
Increased DNA vaccine delivery and immunogenicity by electroporation in vivoG Widera, M Austin, D Rabussay, et al.
Annals of Surgery|September 1, 1995
Gene transfer to the thymus. A means of abrogating the immune response to recombinant adenovirusR P DeMatteo, S E Raper, M Ahn, et al.
Pageof 3